Showing 6811-6820 of 19337 results for "".
Assessing Gastroparesis & Functional Dyspepsia: Should We Use Gastric Emptying Tests?
https://reachmd.com/programs/gi-insights/assessing-gastroparesis-functional-dyspepsia-should-we-use-gastric-emptying-tests/13764/Let’s examine if it’s time to abandon gastric emptying tests in patients with symptoms of gastroparesis and functional dyspepsia.Creating Connection Through Charisma
https://reachmd.com/programs/speaking-of/creating-connection-through-charisma/11917/Charisma isn’t something you get; it’s something you learn. How can speakers use charisma to connect to their audience?Meeting the Needs of Uncontrolled Asthma Patients
https://reachmd.com/programs/deep-breaths-updates-chest/meeting-the-needs-of-uncontrolled-asthma-patients/11670/Even with a timely diagnosis and good adherence, many asthma patients remain symptomatic or uncontrolled. How can we improve their care?Redefining HF Care: The Role of Finerenone in Patients With LVEF ≥40%
https://reachmd.com/clinical-practice/cardiology/redefining-hf-care-the-role-of-finerenone-in-patients-with-lvef-40/36521/Redefining HF Care: The Role of Finerenone in Patients With LVEF ≥40%An Exploration of Multiple Myeloma Treatments
https://reachmd.com/programs/project-oncology/an-exploration-of-multiple-myeloma-treatments/26579/There are a number of treatments for multiple myeloma; however, research is ongoing to improve therapies for optimal patient outcomes. Flip through below for an overview of the different therapies that are available.ADAPT AF-DES: Antithrombotic Strategies Beyond 12 Months for Patients With AF Treated With Drug-Eluting-Stents
https://reachmd.com/clinical-practice/cardiology/adapt-af-des-antithrombotic-strategies-beyond-12-months-for-patients-with-af-treated-with-drug-eluting-stents/48694/Will ADAPT AF-DES findings affect your practice? Tune in for antithrombotic management strategies for patients with drug-eluting stents in the setting of AF.Studying the Safety of Discontinuing DMTs in MS Older Adults
https://reachmd.com/programs/neurofrontiers/studying-the-safety-of-discontinuing-dmts-in-ms-older-adults/15816/A recent study investigated whether stopping therapy in older patients with MS allowed disease activity to increase. Discover the data.Hepatic Encephalopathy: What's Sarcopenia Got to Do With It?
https://reachmd.com/cme/gastroenterology-and-hepatology/hepatic-encephalopathy-whats-sarcopenia-got-to-do-with-it/39663/Learn how PCPs can identify early signs of hepatic encephalopathy to support timely diagnosis and clinical management.The 2-Point Signal: Apply ≥2-Point Rule
https://reachmd.com/programs/cme/the-2-point-signal-apply-2-point-rule/54777/Explore treat-to-target strategies and FcRn inhibitor use to guide outcomes-driven management of generalized myasthenia gravis.The Evolving Landscape of Resectable Locally Advanced HNSCC
https://reachmd.com/programs/cme/the-evolving-landscape-of-resectable-locally-advanced-hnscc/36576/Explore perioperative immunotherapy and multimodal strategies to optimize patient outcomes in resectable locally advanced head and neck squamous cell carcinoma.